Pathology PPM Attempts Public Offering Of Shares
CEO SUMMARY: AmeriPath’s efforts to become a public company make it the most visible management experiment in the pathology world today. Already considered controversial by many pathologists, should AmeriPath successfully pull off its proposed initial public stock offering, it will assume a leadership position in the industry which cannot be ignored. PATHOLOGY MAY SOON have …
Pathology PPM Attempts Public Offering Of Shares Read More »